Protocol for a controlled human infection with genetically modified Neisseria lactamica expressing the meningococcal vaccine antigen NadA: a potent new technique for experimental medicine. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-026544
PubMed Identifier: 31048443
Publication URI: http://europepmc.org/abstract/MED/31048443
Type: Journal Article/Review
Volume: 9
Parent Publication: BMJ open
Issue: 4
ISSN: 2044-6055